CD38
3 papers
- Cells1
Funding
3 grants since 2024National Institute on AgingUS$639.7kNational Cancer InstituteUS$250kNational Institute of Dental and Craniofacial ResearchUS$226.5k
CD38 signaling in aging-associated immune responses induced by oral pathogens
National Institute of Dental and Craniofacial ResearchMedical University of South CarolinaUS$226.5k2025–2027
CD38, T cells and post viral lung sequelae during aging
National Institute on AgingUniversity of VirginiaUS$639.7k2024–2029
Targeting CD38 in HIV-associated Lymphoma
National Cancer InstituteUniversity of Maryland BaltimoreUS$250k2008–2026
Latest
Trends in Pharmacological Sciences
The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging
ReviewCD38
AIDS
Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21
Experiments in human cellsAtorvastatin